Potassium Permanganate Patch for Controlled Skin Treatment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for using potassium permanganate to treat skin disorders are inefficient and hazardous due to non-specific delivery, damage to healthy skin, and the risk of antimicrobial resistance, with no alternative treatments available for patients with resistant infections.

Innovation Solution

A medical-grade silicone patch with dispersed potassium permanganate particles that undergo controlled and sustained release upon contact with an aqueous environment, ensuring targeted delivery and avoiding toxic concentrations, thereby minimizing damage to healthy skin and reducing the risk of resistance.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If potassium permanganate solution is used to treat skin disorders, then antimicrobial effectiveness is improved, but risk of chemical burns and toxicity increases

Engineering Contradiction:
Improveantimicrobial effectivenessVSAvoidchemical burns and toxicity
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies local quality by delivering potassium permanganate specifically to the wound site through a controlled-release dressing, ensuring high concentration where needed while maintaining safe levels elsewhere. The dressing material acts as a reservoir that releases KMnO4 locally at the infection site, preventing systemic exposure and chemical burns to healthy skin.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent utilizes parameter changes by controlling the release rate and concentration of potassium permanganate over time. The controlled-release mechanism transforms the delivery parameters from immediate high concentration to sustained lower concentration, maintaining therapeutic effectiveness while reducing toxicity and preventing chemical burns.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If systemic antibiotics are used to treat infections, then treatment effectiveness is improved, but antimicrobial resistance increases

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidantimicrobial resistance
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent extracts the antimicrobial function from systemic antibiotics by using topical potassium permanganate application. This removes the need for systemic antibiotic exposure that drives resistance, while maintaining effective treatment of the local infection through direct application at the wound site.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent employs potassium permanganate, a strong oxidizing agent, as an alternative to conventional antibiotics. This oxidizing mechanism provides broad-spectrum antimicrobial activity against resistant bacteria without contributing to traditional antibiotic resistance patterns, offering an effective treatment alternative for resistant infections.

Inventive Principle:
Principle #38Strong oxidants (Accelerated oxidation)

3Reliability

If topical antimicrobial treatments are applied, then infection control is improved, but damage to healthy skin occurs

Engineering Contradiction:
Improveinfection controlVSAvoiddamage to healthy skin
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies preliminary action by using a controlled-release dressing that pre-regulates the release of potassium permanganate. The dressing is applied to the wound and automatically releases the antimicrobial agent over time, ensuring infection control at the wound site while preventing excessive exposure to surrounding healthy skin through built-in release control mechanisms.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The patch provides a bioequivalent dose of potassium permanganate to traditional treatments while preventing over-exposure to healthy skin, reducing side effects, and minimizing the risk of resistance, thus offering a safer and more effective treatment for skin disorders.

Implementation Method 1

the patch contains dispersed micro particulate KMnO4 which undergoes dissolution leading to its release in a controlled and sustained manner directly into the treatment site

Methodology Applied
Scientific EffectDissolution: Solvation

Implementation Method 2

The microbicide properties are attributed to its strong oxidising properties

Methodology Applied
Scientific EffectOxidation: Oxidation

Data Source

PatentEP3515416B1Patch comprising potassium permanganate for the treatment of skin disorder
Publication Date: 2023.06.07 ONYA THERAPEUTICS LTD
  • EP3515416B1 patent drawingFigure 1~2
  • EP3515416B1 patent drawingFigure 3
  • EP3515416B1 patent drawingFigure 4~5

AI summary

The invention relates to medical treatment patch, ideally for applying topically, that permits the targeted, sustained and controlled release of potassium KMnO 4; and a method of treating a skin disorder comprising applying said patch.